Company Overview and News

2
IndusInd Bank Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532187 INDUSINDBK

27
Sensex jumps over 261 pts on value-buying, Nifty reclaims 10,772

2018-06-20 freepressjournal.in
Mumbai: Benchmarks snapped their two-session falling streak to finish with smart gains today, spurred by bargain hunting in recently-battered metal and bank stocks amid a rebound in global equities.
YESBANK 500325 INDUSINDBK RELIANCE 532648 YYBKY 533278 500470 TTST 532187 TATASTEEL TATLY HDB 500180 RIGD HDFCBANK CLNDY COALINDIA RLNIY

24
Global cues, RIL, banks lift Sensex 261 pts amid rising trade war fears; InterGlobe dips

2018-06-20 moneycontrol
The market recouped its losses seen in the previous session, following the recovery in its global counterparts on Wednesday amid heightened fears of trade war between the world's largest two economies US and China.
YESBANK INDIGO 500325 PAH KMBKY INDUSINDBK IBN RELIANCE HCTHY 532648 YYBKY 539448 ICICIBANK 532187 HDB 532174 500180 RIGD HCLTECH KOTAKBANK 532281 HDFCBANK 500247 RLNIY

29
Sensex opens in green on value-buying, up 130 points

2018-06-20 freepressjournal.in
Mumbai: The BSE Sensex rebounded over 130 points in opening trade today, reversing its two-session losing streak on value-buying in select blue-chips amid a strengthening rupee. Overseas, mixed trend at other Asian markets also influenced trading sentiments here.
BAJAJ-AUTO YESBANK AXB INDUSINDBK 532648 YYBKY 532977 BHRQY 532215 AXBKY 532454 AXBA 500470 TTST 532187 TATASTEEL TATLY AXISBANK BHARTIARTL

2
IndusInd Bank Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532187 INDUSINDBK

25
Sensex closes 262 pts lower on global weakness after Trump escalates trade threats

2018-06-19 moneycontrol
The market closed sharply lower on Tuesday following correction in its global counterparts after the US President Donald Trump threatened to impose fresh tariffs on China.
500325 KMBKY INDUSINDBK IBN RELIANCE 532978 ICICIBANK BAJAJFINSV BAJFINANCE 532187 HDB 532174 500180 RIGD KOTAKBANK HDFCBANK BJJQY 500247 500570 TATAMOTORS 500034 RLNIY TTM

18
Sensex suffers more losses, down 148 points on global cues

2018-06-19 freepressjournal.in
Mumbai: Benchmark Sensex declined by over 148 points in early trade today, tracking a weak trend in global markets as the trade spat between the US and China intensified. Unabated capital outflows by foreign funds and profit-booking by retail investors too dampened sentiment.
BAJAJ-AUTO INDUSINDBK IBN 532977 533278 500182 ICICIBANK 532187 532174 HEROMOTOCO HRTQY CLNDY COALINDIA

39
Sensex, Nifty turn choppy on weak global cues                 

2018-06-18 freepressjournal.in
Mumbai: The BSE Sensex turned negative after opening 76 points higher in early session today amid weak global cues on rising concerns of a global trade war. The 30-share index was trading lower by 84.09 points, or 0.24 per cent, at 35,538.05. The gauge had gained 22.32 points in the previous session.
BHRQY 533278 532215 500470 532187 AXISBANK HEROMOTOCO 500570 BHARTIARTL TATAMOTORS CLNDY AXB INDUSINDBK IBN AXBKY 500182 532454 AXBA ICICIBANK TTST TATASTEEL TATLY 532174 HRTQY COALINDIA TTM

8
Depositories share info of firms with bourses on FDI limit

2018-06-18 freepressjournal.in
A red flag has been activated in HDFC Bank, Wonderla Holidays, IndusInd Bank, Ashapura Minechem, Cyient and S H Kelkar & Company,
ABBOTINDIA JVLAGRO INDUSINDBK 538268 519248 532187 ASHAPURMIN 527001 HDB 500180 HDFCBANK 500488 WONDERLA

8
Depositories share cos#39; info with exchanges on FDI limits

2018-06-17 moneycontrol
Depositories have shared information about activation of red flag and FDI limit breach related to 12 companies, including HDFC Bank, with the BSE and the NSE, according to notices. As per the separate notices issued by the two bourses, a red flag has been activated in HDFC Bank, Wonderla Holidays, IndusInd Bank, Ashapura Minechem, Cyient Ltd and S H Kelkar and Company.
ABBOTINDIA JVLAGRO INDUSINDBK 538268 519248 532187 ASHAPURMIN 527001 HDB 500180 HDFCBANK 500488 WONDERLA

8
Depositories share info on activation of red flag, breach of FDI limit with bourses

2018-06-17 thehindubusinessline
(PTI) Depositories have shared information about activation of red flag and breach of FDI limit related to 12 companies, including HDFC Bank, with the BSE and the NSE.
ABBOTINDIA ALNSE JVLAGRO INDUSINDBK 538268 519248 532187 ASHAPURMIN 527001 HDB 500180 HDFCBANK 500488 WONDERLA

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...